C-reactive protein associated with the periodontal condition of pregnant women
DOI:
https://doi.org/10.24265/horizmed.2020.v20n2.07Keywords:
C-Reactive protein, Gingivitis, PeriodontitisAbstract
Objective: To determine the C-reactive protein level according to the periodontal state, age and trimester of pregnancy in pregnant women who attend the Centro de Salud Magna Vallejo, Cajamarca, Peru. Materials and methods: An observational, descriptive and cross-sectional study conducted in a sample of 60 pregnant women divided into three groups: those who were periodontally healthy, those with gingivitis and those with periodontitis. The Russell Index was used to determine the periodontal status. The value of the C-reactive protein level was taken from each patient’s medical record. Results: An elevated C-reactive protein level was found in 66.70 % of the pregnant women with gingivitis, 100 % of the pregnant women with periodontitis and 84.60 % of the adult pregnant women. Conclusions: C-reactive protein levels tend to rise in patients with periodontal disease and increase in adult pregnant women.
Downloads
References
Rashidi F, Haerian A, Vaziri F, Khabbazian A, Mohammadi S. CPITN changes during pregnancy and maternal demographic factors' impact on periodontal health. Iran J Reprod Med. 2015; 13(2): 107-12.
Lu H, Xu W, Wei T, Feng X. Impact of periodontal conditions on the quality of life of pregnant women: a cross-sectional study. Health Qual Life Outcomes. 2015; 13: 67.
Gesase N, Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Mahande MJ, Masenga G. The association between periodontal disease and adverse pregnancy outcomes in Northern Tanzania: a cross-sectional study. Afr Health Sci. 2018; 18(3): 601-11.
Makeeva I, Ignatko A, Churganova A, Lebedev V, Makeeva M. Periodontal diseases and complicated pregnancy. Stomatologiia (Mosk). 2019; 98(1): 7-73.
Ersin R, Öngöz F, Gökmenoğlu C, Kara C. Salivary fetuin-A, S100A12, and high-sensitivity C-reactive protein levels in periodontal diseases. Oral Dis. 2018; 24(8): 1554-61.
Ahmad A, Nazar Z, Swaminathan D. C-Reactive Protein levels and periodontal diseases during pregnancy in malaysian women. Oral Health Prev Dent. 2018; 16(3): 281-9.
Tang Y, Fung E, Xu A, Yao H. C-reactive protein and ageing. Clin Exp Pharmacol Physiol. 2017; 44: 9-14.
Martínez V, Carrillo B, Guzmán E, Puerto M, Bermeo J, Pozos A. Proteína C reactiva como marcador inflamatorio en la enfermedad periodontal. Nova Scientia, 2017; 9(2): 51-64.
Manzur F, Alvear C, Alayón A. Papel de la proteína C reactiva en las enfermedades cardiovasculares. Rev Colomb Cardiol 2011; 18(5): 273-8.
Sproston N, Ashworth J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018; 9: 754.
Suarez I, Reyna E, Mejia J, Reyna N, Torres D, Santos J, et al. Proteína C reactiva plasmática en el segundo trimestre para predicción de parto pretérmino. Perinatología y Reproducción Humana. Elsevier. 2016; 30(2): 57-62.
Vecchié A, Bonaventura A, Carbone F, Maggi D, Ferraiolo A, Carloni B, et al. C-Reactive Protein levels at the midpregnancy can predict gestational complications. BioMed Research International. 2018; (3): 1-8.
Ali Z, Bokhari F, Zaki S, Zargham U, Tauseef A, Khakan S. Correlation of CRP levels in third trimester with fetal birth weight in preeclamptic and normotensive pregnant women. J Coll Physicians Surg Pak. 2015; 25(2): 111-4.
Rout R, Mahalik M. Comparison of C-reactive proteins level in gestational hypertension and in normal pregnancy in 2nd and 3rd trimester and its correlation with maternal and foetal outcome. Int J Reprod Contracept Obstet Gynecol. 2019; 8(6): 2541-8.
Wu M, Chen S, Jiang S. Relationship between Gingival Inflammation and Pregnancy. Mediators Inflamm. 2015; 2015: 623427.
Zhong Z, Fu H. Effects of SPR periodontal basic therapy on cervical crevicular fluid C-reactive protein in patients with chronic periodontitis. Shanghai Kou Qiang Yi Xue. 2018; 27(5): 530-4.
Bansal T, Dhruvakumar D, Pandey A. Comparative evaluation of C-reactive protein in peripheral blood of patients with healthy gingiva, gingivitis and chronic periodontitis: A clinical and particle-enhanced turbidimetric immuno-analysis. J Indian Soc Periodontol. 2014; 18(6): 739-43.
Goyal L, Bey A, Gupta N, Sharma V. Comparative evaluation of serum C-reactive protein levels in chronic and aggressive periodontitis patients and association with periodontal disease severity. Contemp Clin Dent. 2014; 5(4): 484-8.
Aoyama N, Suzuki JI, Kobayashi N, Hanatani T, Ashigaki N, Yoshida A, et al. Associations among tooth loss, systemic inflammation and antibody titers to periodontal pathogens in Japanese patients with cardiovascular disease. J Periodontal Res. 2018; 53(1): 117-22.
Sarmiento LR, Velosa J, Arango D, Villegas M, Latorre C, Escobar F. Relación entre la presencia de enfermedad periodontal y el infarto agudo al miocardio por medio de la proteína C reactiva ultrasensible: primera parte. Univ Odontol. 2015; 34(73): 139-48.
Becerra TB, Calla-Poma RD, Requena-Mendizabal MF. Antibacterial effect of peruvian propolis collected during different seasons on the growth of Streptococcus Mutans. Open Denstistry J. 2019; 13(1): 327-31.
Huang W, Wu J, Mao Y, Zhu S, Huang GF, Petritis B, et al. Developing a periodontal disease antibody array for the prediction of severe periodontal disease using machine learning classifiers. J Periodontol. 2020; 91(2): 232-43.
Musalaiah S, Anupama M, Nagasree M, Krishna CM, Kumar A, Kumar PM. Evaluation of nonsurgical periodontal therapy in chronic periodontitis patients with anemia by estimating hematological parameters and high-sensitivity C-reactive protein levels. J Pharm Bioallied Sci. 2014; 6(Suppl. 1): S64-9.
Atta J, Ahmed Z, Aslam N, Nawaz H, Das T, Ali Z. C-reactive protein in patients with preeclampsia. Indo Am J Pharm Sci. 2017; 4(3).
Peña E, Reyna E, Mejia J, Reyna N, Torres D, Santos J. Proteína C Reactiva en pacientes con preeclampsia y gestantes normotensas sanas. Clin Invest Gin Obst. 2016; 43(1): 7-11.
Vecchié A, Bonaventura A, Carbone F, Maggi D, Ferraiolo A, Carloni B, et al. C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications. Biomed Res Int. 2018.
The World Bank. World Development Indicators [Internet]. 2020. Disponible en: https://databank.worldbank.org/reports.aspx?source=2&series=SH.DYN.NMRT&country=
Araya C, Galindo MP. Tamaño de la muestra en investigación clínica. Med Clin (Barc). 2009; 133(1): 26-30.
Bascones A. Periodoncia clínica e implantología oral. Ediciones Avances. Barcelona. 2009.
Química Clínica Aplicada. Látex PCR directo. Test en placa para la determinación in vitro de la Proteína C Reactiva. 2009.
Ministerio de Salud del Perú. Estrategia Sanitaria Nacional De Salud Bucal [Internet]. 2014. Disponible en: https://www.minsa.gob.pe/portalweb/06prevencion/prevencion_2.asp?sub5=13
Mannava P, Gokhale S, Pujari S, Biswas KP, Kaliappan S, Vijapure S. comparative evaluation of C-reactive Proteins in pregnant women with and without periodontal pathologies: a prospective cohort analysis. J Contemp Dent Pract. 2016; 17(6): 480-3.
Wyczalkowska A, Czarkowska B, Zielenkiewicz M, Paczek L. Inflammatory markers change with age, but do not fall beyond reported normal ranges. Arch Immunol Ther Exp. 2016; 64: 249-54.
Opeodu I, Dosumu E, Arowojolu M. periodontal condition and treatment needs of some pregnant women in Ibadan, Nigeria. Ann Med Health Sci Research. 2015; 5(3): 213-7.
Kashetty M, Kumbhar S, Patil S, Patil P. Oral hygiene status, gingival status, periodontal status, and treatment needs among pregnant and nonpregnant women: a comparative study. J Indian Soc Periodontol. 2018; 22(2): 164-70.
Lasserre J, Brecx M, Toma S. Oral microbes, biofilms and their role in periodontal and peri-implant diseases. Materials (Basel). 2018; 11(10): 1802.
Vieira A, Magalhães C, Hartenbach F, Martins do Souto R, Maciel da Silva C. Periodontal-disease-associated biofilm: A reservoir for pathogens of medical importance. Microb Pathog. 2016; 94: 27-34.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).